2005
DOI: 10.1080/09638280500164479
|View full text |Cite
|
Sign up to set email alerts
|

Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis

Abstract: The shorter distance covered during a 6MWT is determined by the limitations in activities of daily living,resting heart rate and subjective symptomatic fatigue in ambulatory patients with MS. Respiratory muscle weakness, lung function and level of neurological impairment do not contribute to impaired functional exercise capacity in these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
113
0
5

Year Published

2008
2008
2019
2019

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 156 publications
(129 citation statements)
references
References 31 publications
11
113
0
5
Order By: Relevance
“…Among patients with neurological disorders, the slower they move, the higher are the sensory-motor and cognitive dysfunctions 3,20,21 .…”
Section: Reliability Testmentioning
confidence: 99%
See 1 more Smart Citation
“…Among patients with neurological disorders, the slower they move, the higher are the sensory-motor and cognitive dysfunctions 3,20,21 .…”
Section: Reliability Testmentioning
confidence: 99%
“…It is necessary to monitor the progress of patients and to seek scientific evidence based on the various types of therapeutic interventions. Thus, it is important to have gait assessment scales for MS [1][2][3] .…”
mentioning
confidence: 99%
“…Doing so may help manage the many disabling symptoms often associated with the disease including muscle weakness 2 , reduced balance 3,4 , reduced mobility 3 , reduced exercise tolerance 5,6 and fatigue 7 . Cumulative evidence suggests that exercise may help improve some of these symptoms [8][9][10] .…”
Section: Introductionmentioning
confidence: 99%
“…Originally developed to assess disability in patients with chronic obstructive lung disease, the 6-minute walk test (6MWT) has since been extensively studied and used with older persons and persons with heart failure, pulmonary hypertension, cardiovascular conditions, stroke, obesity, human immunodeficiency virus, acquired brain injury, adult cerebral palsy, and MS. [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] Reference values for the 6MWT are reported for people aged 20 to 50 15 and 55 to 75 years. 16 Performance on the 6MWT is influenced by many factors, including age, 16,19,20,22 gender, 20 race, 20 height, 20 weight, 17,20 health condition (medications, 14 ), and psychological conditions (depression, cognition, affect).…”
Section: Introductionmentioning
confidence: 99%